| scholarly article | Q13442814 |
| P50 | author | Paul Ridker | Q7153226 |
| Julie E. Buring | Q67224421 | ||
| David Conen | Q94595757 | ||
| Lynda M Rose | Q102229680 | ||
| Christine M. Albert | Q115937216 | ||
| Nancy Cook | Q58494310 | ||
| P2093 | author name string | Brendan M Everett | |
| Usha B Tedrow | |||
| P2860 | cites work | Alcohol consumption and risk of incident atrial fibrillation in women | Q24645595 |
| A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women | Q28218670 | ||
| Inflammation in atherosclerosis | Q29547428 | ||
| C-Reactive Protein is a Risk Indicator for Atrial Fibrillation After Myocardial Revascularization | Q60680958 | ||
| Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia | Q73936941 | ||
| A collaborative study to establish the 2nd International Standard for Fibrinogen, Plasma | Q74226027 | ||
| C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation | Q77337410 | ||
| Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: possible involvement in intracardiac thrombogenesis | Q79370078 | ||
| Fibrinogen and albumin levels and risk of atrial fibrillation in men and women (the Copenhagen City Heart Study) | Q79753558 | ||
| Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events | Q79975604 | ||
| Effects of C-reactive protein and the third and fourth components of complement (C3 and C4) on incidence of atrial fibrillation | Q82404894 | ||
| Inflammation and atrial fibrillation: cause or para-phenomenon? | Q84300860 | ||
| Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study | Q29614197 | ||
| Atrial fibrillation as an independent risk factor for stroke: the Framingham Study | Q29614200 | ||
| Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men | Q29619308 | ||
| Relation of multiple inflammatory biomarkers to incident atrial fibrillation | Q33573035 | ||
| Role of inflammation and oxidative stress in atrial fibrillation | Q33746384 | ||
| Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation | Q34396457 | ||
| Inflammation as a risk factor for atrial fibrillation | Q34543274 | ||
| Histological substrate of atrial biopsies in patients with lone atrial fibrillation | Q34742809 | ||
| Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community | Q35575045 | ||
| A perspective on antiarrhythmic drug therapy to treat atrial fibrillation: there remains an unmet need | Q36434209 | ||
| Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women | Q37332761 | ||
| Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence | Q40310174 | ||
| Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. | Q40872170 | ||
| C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation | Q43854958 | ||
| Impact of atrial fibrillation on the risk of death: the Framingham Heart Study | Q45222306 | ||
| Alcohol consumption and risk of atrial fibrillation in men and women: the Copenhagen City Heart Study | Q46699218 | ||
| Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk | Q46786274 | ||
| Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation | Q46985526 | ||
| Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. | Q50972617 | ||
| A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. | Q55036185 | ||
| Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality | Q57073207 | ||
| Secular trends in the prevalence of atrial fibrillation: The Framingham study | Q57073337 | ||
| P433 | issue | 14 | |
| P921 | main subject | inflammation | Q101991 |
| Atrial Fibrillation | Q815819 | ||
| P304 | page(s) | 1730-1736 | |
| P577 | publication date | 2010-05-25 | |
| P1433 | published in | European Heart Journal | Q2286839 |
| P1476 | title | A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women | |
| P478 | volume | 31 |
| Q37240656 | Advanced Left Atrial Remodeling and Appendage Contractile Dysfunction in Women Than in Men Among the Patients With Atrial Fibrillation: Potential Mechanism for Stroke |
| Q35908462 | Age of natural menopause and atrial fibrillation: the Framingham Heart Study |
| Q33721705 | Are cardiovascular risk factors also associated with the incidence of atrial fibrillation? A systematic review and field synopsis of 23 factors in 32 population-based cohorts of 20 million participants. |
| Q38738095 | Association Between Vascular Cell Adhesion Molecule 1 and Atrial Fibrillation |
| Q49972109 | Association of lipoprotein-associated phospholipase A2 and risk of incident atrial fibrillation: Findings from 3 cohorts |
| Q38065252 | Atherosclerosis and thromboembolic risk in atrial fibrillation: focus on peripheral vascular disease. |
| Q30234626 | Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes |
| Q56607936 | Atrial fibrillation |
| Q36514164 | Atrial fibrillation is associated with hematopoietic tissue activation and arterial inflammation |
| Q34342621 | B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies |
| Q38317687 | Bridging the gender gap in atrial fibrillation |
| Q33160813 | C-reactive protein levels in the brugada syndrome. |
| Q38372615 | CHA2DS2-VASc Score: A Predictor of Thromboembolic Events and Mortality in Patients With an Implantable Monitoring Device Without Atrial Fibrillation |
| Q94595761 | Change in Atrial Fibrillation Burden over Time in Patients with Nonpermanent Atrial Fibrillation |
| Q34680346 | Chronic Inflammation: Accelerator of Biological Aging |
| Q36016780 | Chronic Kidney Disease and the Risk of New-Onset Atrial Fibrillation: A Meta-Analysis of Prospective Cohort Studies |
| Q35609742 | Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference |
| Q39683930 | Cyclooxygenase-2 inhibitors and cardiovascular risk in a nation-wide cohort study after the withdrawal of rofecoxib |
| Q36152831 | Determinants of Left Atrial Volume in Patients with Atrial Fibrillation. |
| Q82503473 | Endothelial Dysfunction and Atrial Fibrillation: What is the Relationship? |
| Q40502984 | Estimated glomerular filtration rate within the normal or mildly impaired range and incident non-valvular atrial fibrillation: Results from a population-based cohort study |
| Q38861510 | Heart rate, heart rate variability and inflammatory biomarkers among young and healthy adults |
| Q37496133 | Impact of Atrial Fibrillation On Cardiovascular Mortality in the Setting of Myocardial Infarction |
| Q42604095 | Increased risk of atrial fibrillation in patients with coeliac disease: a nationwide cohort study |
| Q38333088 | Inflammation and the pathogenesis of atrial fibrillation. |
| Q44303150 | Inflammation, blood pressure and cardiovascular disease: heading east |
| Q35913178 | Interleukin-6 Is a Risk Factor for Atrial Fibrillation in Chronic Kidney Disease: Findings from the CRIC Study |
| Q34615040 | Multiple inflammatory biomarker detection in a prospective cohort study: a cross-validation between well-established single-biomarker techniques and an electrochemiluminescense-based multi-array platform |
| Q90619695 | Negative Affect and Risk of Atrial Fibrillation: MESA |
| Q34603226 | Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes |
| Q37061256 | Novel genetic markers improve measures of atrial fibrillation risk prediction |
| Q91605949 | Pre-ablation levels of brain natriuretic peptide are independently associated with the recurrence of atrial fibrillation after radiofrequency catheter ablation in patients with nonvalvular atrial fibrillation |
| Q35021968 | Predisposing factors associated with development of persistent compared with paroxysmal atrial fibrillation. |
| Q36108990 | Relation of renal function to risk for incident atrial fibrillation in women |
| Q59304831 | Relationship between QRS duration and incident atrial fibrillation |
| Q36815158 | Risk factors for incident atrial fibrillation with and without left atrial enlargement in women |
| Q37118899 | Risk of Malignant Cancer Among Women With New-Onset Atrial Fibrillation |
| Q38486305 | Role of tumor necrosis factor alpha in the pathogenesis of atrial fibrillation: A novel potential therapeutic target? |
| Q24594814 | Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective |
| Q53836636 | Stroke in atrial fibrillation and improving the identification of 'high-risk' patients: the crossroads of immunity and thrombosis. |
| Q37602866 | Targeting inflammation and oxidative stress in atrial fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins. |
| Q40908186 | The interrelationships of birthweight, inflammation and body composition in healthy adults |
| Q37446317 | The risk of atrial fibrillation in patients with rheumatoid arthritis |
| Q26864987 | The role of oxidative stress and inflammation in cardiovascular aging |
| Q34779355 | Type 2 diabetes mellitus and risk of incident atrial fibrillation in women |
| Q90461108 | Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study |
Search more.